INR:1833. betfair app for iphone AstraZeneca's Brinlinta gets FDA approval for high-risk coronary artery disease patients Retrophin acquires Orphan for $51 ...

California is known for its residents' healthy lifestyles, but what does that mean for heart disease mortality risk if you ...

In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through ...

Most people are aware of the risks of carrying too much fat around the waist and hips, but there’s another kind of fat—hidden ...

The year held a number of surprises, including a few negative studies, as well as a big win for Impella in DanGer Shock.

FastWave Medical's technology delivers energy pulses to break up plaque in arteries caused by coronary artery disease and ...

I’ ve heard about several people who have experienced sudden cardiac arrest. What is cardiac arrest? And how is it different ...

This study is the first to inject repeated doses of stem cells intravenously into patients who have heart failure due to a heart attack or coronary artery disease.

With new data from several studies this year, researchers are chipping away at the question of when to revascularize and how.

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with ...

Forty thousand people each year will suffer from this rarely-diagnosed disease, but many people don’t know it exists.

Despite advances in prevention and optimal medical therapy, coronary artery disease (CAD) remains the leading cause of morbidity and mortality worldwide.